Astrocytes are GABAergic cells that modulate microglial activity
Article first published online: 2 NOV 2010
Copyright © 2010 Wiley-Liss, Inc.
Volume 59, Issue 1, pages 152–165, January 2011
How to Cite
Lee, M., Schwab, C. and Mcgeer, P. L. (2011), Astrocytes are GABAergic cells that modulate microglial activity. Glia, 59: 152–165. doi: 10.1002/glia.21087
- Issue published online: 12 NOV 2010
- Article first published online: 2 NOV 2010
- Manuscript Accepted: 9 SEP 2010
- Manuscript Received: 20 JUN 2010
- Pacific Alzheimer Research Foundation
- glutamic acid decarboxylase;
- GABA transaminase;
- GABAA receptor;
- GABAB receptor
GABA is assumed to function in brain only as an inhibitory neurotransmitter. Here we report a much broader CNS role. We show that human astrocytes are GABAergic cells, and that human microglia are GABAceptive cells. We show that in adult human brain tissue, astrocytes immunostain for the GABA synthesizing enzyme GAD 67, the GABA metabolizing enzyme GABA-T and the GABAA and GABAB receptors. The intensity of staining is comparable or greater to that observed for known inhibitory neurons. We show that cultured human astrocytes strongly express the mRNA and protein for GAD 67, as well as GABA-T, and the GABAA and GABAB receptors. We further show that cultured human microglia express the mRNA and protein for GABA-T, in addition to the GABAA and GABAB receptors characterizing them as GABAceptive cells. We demonstrate that GABA suppresses the reactive response of both astrocytes and microglia to the inflammatory stimulants lipopolysaccharide (LPS) and interferon-γ by inhibiting induction of inflammatory pathways mediated by NFκB and P38 MAP kinase. This results in a reduced release of the inflammatory cytokines TNFα and IL-6 and an attenuation of conditioned medium neurotoxicity toward neuroblastoma SH-SY5Y cells. These inhibitory reactions are partially mimicked by the GABAA receptor agonist muscimol and the GABAB receptor agonist baclofen, indicating that GABA can stimulate both types of receptors in astrocytes as well as microglia. We conclude that the antiinflammatory actions of GABA offer new therapeutic opportunities since agonists should enhance the effectiveness of other antiinflammatory agents that operate through non-GABA pathways. © 2010 Wiley-Liss, Inc.